ReviewJournal of gastrointestinal cancer2026
Who Truly Benefits from Anti-EGFR Rechallenge in Metastatic Colorectal Cancer? From Clinical Enrichment to ctDNA-Guided Molecular Hyperselection.
Tamotsu Sagawa et al.PubMed ↗Publisher ↗
No numbers read from the abstract.